MTOR and breast carcinoma: However, our observation as frequent deregulation in the PDK-1/AKT/mTOR/p70S6K signalling pathway and its prognostic role in breast cancers implicated the notion of using inhibitors to impair this pathway and to provide additional strategy to treat breast cancer.